Cerebellar cGMP levels reduced by morphine and pentobarbital on a dose- and time-dependent basis.
D000818:Animals; D002531:Cerebellum / Q000187:drug effects / Q000378:metabolism*; D006152:Cyclic GMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004361:Drug Tolerance; D006801:Humans; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D010424:Pentobarbital / Q000494:pharmacology*; D051381:Rats; D013375:Substance Withdrawal Syndrome; D013997:Time Factors
D009270:Naloxone; D009020:Morphine; D006152:Cyclic GMP; D010424:Pentobarbital